Workflow
Asia Healthcare_ Evolving CDMO landscape_ #4_ Biosecure Act not included in FY25 NDAA; updated scenario analysis and investor feedback
AstraZeneca·2024-12-15 16:04

shuinu9870 shuinu9870 shuinu9870 更多一手调研纪要和研报数据加V: 更多一手调研纪要和研报数据加V: 更多一手调研纪要和研报数据加V: 更多资料加入知识星球:水木调研纪要 关注公众号:水木纪要 12 December 2024 | 7:35PM HKT shuinu9870 shuinu9870 更多一手调研纪要和研报数据加V: shuinu9870 shuinu9870 更多一手调研纪要和研报数据加V: Asia Healthcare: Evolving CDMO landscape #4: Biosecure Act not included in FY25 NDAA; updated scenario analysis and investor feedback shuinu9870 更多一手调研纪要和研报数据加V: 更多一手调研纪要和研报数据加V: On December 7th, the US House and Senate Armed Services Committees released the text of the final negotiated lan ...